Hims & Hers Health, Inc. (HIMS) has 33 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 9 sales totalling $7.1M. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 17, 2026 | Okupe Oluyemi Chief Financial Officer | −$354,861 | 12,313 | −5% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 16, 2026 | Boughton Soleil Chief Legal Officer | −$173,735 | 6,236 | −2% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | Chi Michael Chief Operating Officer | −$398,227 | 14,027 | −3% | Yes | |
|
|
||||||
| Sept. 17, 2026 filed Sept. 15, 2026 | Elshenawy Mohamed CTO | −$225,814 | 7,954 | −4% | Yes | |
|
|
||||||
| Aug. 27, 2026 filed Aug. 25, 2026 | Dudum Andrew Chief Executive Officer | $0 | 1,440,855 | −93% | No | |
|
|
||||||
Showing the 5 most recent of 33 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free